Report cover image

Botanical and Plant-derived Drugs: Global Markets

Publisher BCC Research
Published Dec 10, 2025
Length 135 Pages
SKU # WA20658061

Description

Report Scope

The report provides an overview of the global market for botanical and plant-derived drugs and analyzes market trends. It includes global revenue ($ million) for 2024 as the base year data and estimated data for the forecast period, which is 2025 through 2030. The market is segmented based on product, application and region. By type, the market is segmented into plant-derived drugs and botanicals.

This report primarily focuses on drugs, rather than supplements or dietary substitutes. By application, the market is segmented into cancer, cardiovascular diseases, central nervous system disorders, infectious diseases and other. The regions covered in this study include North America, Europe, Asia-Pacific and the Rest of the World, with additional focus on major countries in these regions. North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe. The Asia-Pacific region includes China, Japan, India, South Korea, and the Rest of Asia-Pacific. Rest of the world includes South America and Middle East and Africa.

This report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social, and corporate governance (ESG) developments. The report includes an analysis of the competitive landscape, with a focus on the key firms in the global market. It also has a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments.

Report Includes
  • 47 data tables and 47 additional tables
  • An overview of the global market for botanical and plant-derived drugs
  • In-depth analysis of global market trends, featuring historical revenue data for 2022–2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
  • Evaluation of the current market size and revenue growth prospects specific to the botanical and plant-derived drugs, accompanied by a market share analysis by type, application and region
  • Analysis of current and future demand in the botanical and plant-derived drugs, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
  • Detailed information on some of the botanical or plant products that have received FDA approval for prescription medications, such as Veregen and Fulyzaq, and a discussion of their therapeutic advantages over synthetic substitutes
  • Analysis of drivers, challenges and opportunities affecting market growth
  • Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
  • Market share analysis of the key market participants of the industry, along with their research priorities, product portfolios, global rankings and competitive landscape
  • Profiles of major companies within the industry, including Bayer, Novartis, Jaguar Health Inc., Jazz Pharmaceuticals, and Bristol Myers Squibb Co.


Companies Mentioned

Ani Pharmaceuticals Inc.
Bayer Ag
Bristol-myers Squibb Co.
Chiesi Farmaceutici S.P.A.
Fresenius Kabi Ag
Gsk Plc
Jaguar Health
Jazz Pharmaceuticals Inc.
Johnson & Johnson
Mallinckrodt
Mediwound
Novartis Ag
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.

Table of Contents

135 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
History Of Plant-derived Medicines
Ancient Egyptian Healing Practices (Circa 1500 Bce)
Chinese Herbal Medicine (Ancient Times)
Plant-derived Products In The Traditional Pharmacopeias
Quinine: A Malaria Breakthrough From Cinchona (17th Century)
Aspirin: A Gift From The Willow Tree (19th Century)
Botanical Drugs Value Chain
Cultivation And Collection
Primary Processing
Regulatory, Manufacturing And Consumers
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact Of U.S. Tariffs
Porter's Five Forces Analysis
Potential Of New Entrants: Moderate To High
Bargaining Power Of Suppliers: Moderate To High
Bargaining Power Of Buyers: Moderate
Threat Of Substitute Products Or Services: Moderate
Level Of Competitiveness: High
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Shift In Consumer Preference For Natural-origin Therapeutics
Favorable Safety And Tolerability Profile
Advances In Extraction, Purification, And Analytical Technologies
Aging Population And The Growing Prevalence Of Chronic Diseases
Supportive Regulatory Frameworks
Market Restraints
Complex Composition And Lack Of Standardization
Lack Of Funding For Botanical Drugs R&D
Market Opportunities
Application Of Plant Metabolites For Drug Discovery
Growing Biotechnological Integration For Personalized Medicine Development
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Other Countries
Chapter 5 Emerging Technologiesand Developments
Key Takeaways
Single-omics Approaches
Multi-omics Approaches
Fermentation Technology
Pipeline Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis By Product Type
Key Takeaways
Botanical Drugs
Plant-derived Drugs
Market Analysis By Application
Key Takeaways
Cancer
Cardiovascular Diseases
Central Nervous System Disorders
Infectious Diseases
Others
Geographic Breakdown
Market Analysis By Region
North America
Europe
Asia-pacific
Rest Of The World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Large Pharmaceutical Companies
Botanical Drug Companies
Strategic Initiatives
Chapter 8 Sustainability In The Botanical And Plant-derived Drugs Market: An Esg Perspective
Introduction To Esg
Sustainability Trends And Initiatives Of The Botanical And Plant-derived Drugs Industry
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Acronyms
Company Profiles
Ani Pharmaceuticals Inc.
Bayer Ag
Bristol-myers Squibb Co.
Chiesi Farmaceutici S.P.A.
Fresenius Kabi Ag
Gsk Plc
Jaguar Health
Jazz Pharmaceuticals Inc.
Johnson & Johnson
Mallinckrodt
Mediwound
Novartis Ag
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Emerging Start-ups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us